IN8BIO, Inc.
INAB· Nasdaq
INABIN8BIO, Inc.
Filed Nov 6, 2025 · 10-Q · 37 days after period end · 0001193125-25-269447
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$3.85M | -$7.09M | -$7.17M | -$7.40M |
| EPS Diluted | -$0.85 | -$4.49 | -$0.23 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IN8BIO, Inc. · CIK 1740279 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d after period end
